AEQUITA PHARMACY FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • No warning letters matched by name
Inspections 0 0 OAI
Recalls 13 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

AEQUITA PHARMACY has 13 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "AEQUITA PHARMACY" is on file.

What these totals cover: FDA records filed under the name "AEQUITA PHARMACY".

Latest recall
D-0564-2025 · Class II · Jul 18, 2025

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls13Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections0Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing AEQUITA PHARMACY as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check AEQUITA PHARMACY yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

13 recall records on Jul 18, 2025.

NumberClassProductDate
D-0564-2025Class IISemaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50…Jul 18, 2025
D-0558-2025Class IITirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0560-2025Class IITirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0559-2025Class IITirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0555-2025Class IITirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0556-2025Class IITirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0563-2025Class IISemaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0561-2025Class IISemaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0565-2025Class IISemaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0562-2025Class IISemaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0554-2025Class IITirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0557-2025Class IITirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025
D-0553-2025Class IISemaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe)…Jul 18, 2025

AEQUITA PHARMACY and the FDA: common questions

Has AEQUITA PHARMACY received an FDA warning letter?

No FDA warning letter addressed to the name "AEQUITA PHARMACY" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has AEQUITA PHARMACY received an FDA Form 483?

FDA has not published a Form 483 for "AEQUITA PHARMACY" in its reading room. FDA publishes some Form 483s, not all of them.

Has AEQUITA PHARMACY had an FDA recall?

Yes. AEQUITA PHARMACY has 13 FDA recalls on record. The most recent started Jul 18, 2025.

Need more than this page shows? Ask about AEQUITA PHARMACY in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.